Meningococcal B vaccine in the private market

5 October 2016

GSK has advised that a limited supply of the meningococcal B vaccine (Bexsero) has now become available and will be provided to all Australian wholesalers via an allocation process to ensure equitable access.

Due to the limited supplies released, GSK anticipates availability will remain intermittent in the private market for the remainder of 2016. The advice on the GSK website will not be changed. The TGA website will be updated in the coming days.

GSK doesn’t expect the current constraints to extend into 2017, and will provide a further update regarding supply in January 2017.

For further information, GSK Medical Information can be contacted on 1800 033 109.